Veterinary Medicines

Cepravin Dry Cow 250 mg Intramammary suspension

Authorised
  • Cefalonium dihydrate
Download as PDF

Product identification

Medicine name:
CEPRAVRIN DRY COW 250 mg suspensie voor intramammair gebruik voor runderen
Cepravin Dry Cow 250 mg Intramammary suspension
Active substance:
  • Cefalonium dihydrate
Target species:
  • Cattle (dairy cow at drying-off)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefalonium dihydrate
    269.60
    milligram(s)
    /
    1.00
    Applicator
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow at drying-off)
      • Meat and offal
        21
        day
      • Milk
        96
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DB90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • (ID2) 432 gram(s): Behältnis with 144 Syringe (PolyEthylene) each with 3 gram(s), closed with Lid (PolyEthylene)
  • (ID1) 60 gram(s): Box (Cardboard) with 20 Syringe (PolyEthylene) each with 3 gram(s), closed with Lid (PolyEthylene)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Trirx Segre
  • Intervet International GmbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 110469
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0184/001
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Estonia
  • Latvia
  • Netherlands

Documents

Combined File of all Documents

English (PDF)
Published on: 30/01/2024
Download
Dutch (PDF)
Published on: 27/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."